Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
GROW Funds delivered exceptional Q3 2025 returns (+18% to +25% net) by tilting towards undervalued small/mid-cap healthcare and AdTech innovators while strictly avoiding mega-cap AI valuation traps.
Full Quick Take
GROW Funds delivered exceptional Q3 2025 returns (+18% to +25% net) by tilting towards undervalued small/mid-cap healthcare and AdTech innovators while strictly avoiding mega-cap AI valuation traps.
